A lack of international consensus on definitions of hyperparathyroidism related to end-stage renal disease leads to heterogeneity in treatment: In response to the letter to the editor by Sharanappa et al

Abstract

We would like to thank Sharanappa and colleagues for their interest and letter to the editor in response to our article entitled “Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease” published in Surgery.1 van der Plas W. Kruijff S. Sidhu S.B. Delbridge L.W. Sywak M.S. Engelsman A F. Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease. Surgery. 2021; 169: 275-281 Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar Letter to editor in response to the article “Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease” by Willemijn van der Plas et al published in SurgerySurgeryVol. 169Issue 5PreviewWe read with interest the article titled “Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease” by Willemijn van der Plas et al and congratulate the authors for exploring the option of limited surgery in carefully selected patients.1 Due to asymmetrical parathyroid hyperplasia in patients with renal hyperparathyroidism, resection of less than 3.5 glands has not been considered adequate due to the risk of persistent/recurrent disease, but as the article was aptly titled, looking at the option of limited exploration is the need of the day. Full-Text PDF